|2nd July 2015
Head of Customer Experience Elisa del Galdo talks through the key considerations for pharma companies when designing and delivering digital patient services from a customer experience perspective.
As pharma marketing departments increasingly look towards digital services and solutions, there are a number of important considerations that companies cannot afford to neglect. Understanding client objectives should be the first port of call. When talking about innovation in marketing, the creation of digital services and multi-platform offerings often comes up. There has been a great deal of innovation applied to the provision of digital services and solutions within the pharmaceutical industry, in spite of the unique challenges created by strict regulations on the marketing of medical products. That said, the design and development of customer-focused services and solutions is a relatively new approach in this sector.
This article has appeared in the IPT Online - Innovations in Pharmaceutical Technology June 2015 issue.
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?
|28th July 2020
At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
|14th July 2020
Blue Latitude Health, and our parent company Fishawack Health, have developed exclusive intellectual property, processes and tools to ensure you’re engaging customers in the right way. View our service one-pagers below to find out how we can help solve your challenges whether you’re in a medical, brand, portfolio or an above brand role.